e-Drug3D 467 |
TRIAZOLAM
|
cas 28911-01-5 |
CLASS NERVOUS SYSTEM |
ROUTE (list) ORAL |
ATC code |
PK parameters Tmax 2 HOUR Solubility POORLY SOLUBLE IN WATER |
Target TARGET GAMMA-AMINOBUTYRIC-ACID RECEPTOR (GABA) |
DrugCentral GABA-A receptor alpha-1,beta-2,gamma-2 UNIPROT P14867 GABRA1 GABA-A receptor alpha-2,beta-3,gamma-2 UNIPROT P18507 GABRG2 |
Download SDF file | 8-chloro-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine Formula: Calculated chemical properties: MW 343.21 NB_atoms 23 XLogP 4.23 PSA 38.113 NB_HD 0 NB_HA 4 fsp3 0.12 Lipinski(0=no;1=yes) 1 |
FDA NDA 017892 (pdf not found) INN (TRIAZOLAM) HALCION (PFIZER) APPROVAL= AP YEAR= 1982 NDA 074031 (pdf not found) INN (TRIAZOLAM) TRIAZOLAM (PHARMOBEDIENT) APPROVAL= AP YEAR= 1994 DISCONTINUED NDA 074224 (pdf not found) INN (TRIAZOLAM) TRIAZOLAM (HIKMA) APPROVAL= AP YEAR= 1994 DISCONTINUED NDA 074445 (pdf not found) INN (TRIAZOLAM) TRIAZOLAM (WATSON LABS) APPROVAL= AP YEAR= 1995 DISCONTINUED NDA 214219 (pdf not found) INN (TRIAZOLAM) TRIAZOLAM (NOVAST LABS) APPROVAL= AP YEAR= 2020 NDA 213003 (pdf not found) INN (TRIAZOLAM) TRIAZOLAM (ZYDUS PHARMS) APPROVAL= AP YEAR= 2022 NDA 216890 (pdf not found) INN (TRIAZOLAM) TRIAZOLAM (BRECKENRIDGE) APPROVAL= AP YEAR= 2022 |
Other links: |